The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((1S,2S)-2-amino-3,3-difluorocyclohexyl)-5-methyl-4-(6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl)thiophene-2-carboxamide ID: ALA4561857
PubChem CID: 155559157
Max Phase: Preclinical
Molecular Formula: C22H23F2N7OS
Molecular Weight: 471.54
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1sc(C(=O)N[C@H]2CCCC(F)(F)[C@H]2N)cc1-c1cnn2cc(-c3cnn(C)c3)cnc12
Standard InChI: InChI=1S/C22H23F2N7OS/c1-12-15(6-18(33-12)21(32)29-17-4-3-5-22(23,24)19(17)25)16-9-28-31-11-13(7-26-20(16)31)14-8-27-30(2)10-14/h6-11,17,19H,3-5,25H2,1-2H3,(H,29,32)/t17-,19-/m0/s1
Standard InChI Key: NWBOEANZBJNTRF-HKUYNNGSSA-N
Molfile:
RDKit 2D
33 37 0 0 0 0 0 0 0 0999 V2000
17.9823 -19.1173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9823 -19.9345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6876 -20.3390 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6876 -18.7046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3929 -19.1173 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3929 -19.9355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1710 -20.1884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6520 -19.5265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1711 -18.8646 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4251 -20.9698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9448 -21.6309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4251 -22.2921 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.2023 -22.0396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2023 -21.2224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8635 -22.5199 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7780 -23.3326 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.6100 -22.1875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2708 -18.7076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1830 -17.8952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3832 -17.7276 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9766 -18.4366 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5253 -19.0422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0486 -16.9821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2711 -22.6679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1276 -21.6308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1818 -23.4799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8389 -23.9597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5875 -23.6310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6749 -22.8176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0138 -22.3328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0991 -21.5201 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0770 -22.1054 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
25.4898 -22.8153 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 2 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 10 1 0
7 10 1 0
13 15 1 0
15 16 2 0
15 17 1 0
18 19 2 0
19 20 1 0
20 21 1 0
21 22 2 0
22 18 1 0
1 18 1 0
20 23 1 0
24 17 1 6
11 25 1 0
24 26 1 0
24 30 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 6
29 32 1 0
29 33 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 471.54Molecular Weight (Monoisotopic): 471.1653AlogP: 3.41#Rotatable Bonds: 4Polar Surface Area: 103.13Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.97CX LogP: 2.65CX LogD: 2.52Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.47Np Likeness Score: -1.40
References 1. Sloman DL, Noucti N, Altman MD, Chen D, Mislak AC, Szewczak A, Hayashi M, Warren L, Dellovade T, Wu Z, Marcus J, Walker D, Su HP, Edavettal SC, Munshi S, Hutton M, Nuthall H, Stanton MG.. (2016) Optimization of microtubule affinity regulating kinase (MARK) inhibitors with improved physical properties., 26 (17): [PMID:27491711 ] [10.1016/j.bmcl.2016.02.003 ]